Full Text View
Tabular View
Study Results
Related Studies
A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age
This study has been terminated.
( The study was closed prior to enrollment of Cohort 2 due to a non-safety related sponsor decision. )
Study NCT00508651   Information provided by MedImmune LLC

First Received on July 27, 2007.   Last Updated on November 28, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Healthy
Additional conditions recognized in this trial
Paramyxoviridae Infections
More general conditions related to this trial
Mononegavirales Infections
RNA Virus Infections
Virus Diseases
Interventions listed in this trial
MEDI-560
Placebo
Sponsors listed in this trial
MedImmune LLC


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services